SCHEMBL2332

SCHEMBL2332

Sc1[c]cccc1S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10532634 0.80
SCHEMBL10924037 0.75 ALDH1A1 (0.33)
SCHEMBL10530444 0.75
SCHEMBL972683 0.75
SCHEMBL10534179 0.75
SCHEMBL27700937 0.75
SCHEMBL10534196 0.75
SCHEMBL972189 0.75
SCHEMBL6309568 0.75
SCHEMBL10530415 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 10053 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024131776-A1 BUFALIN DERIVATIVE AND PREPARATION METHOD THEREFOR, COMPOSITION, PREPARATION, AND APPLICATION 上海邈基生物科技有限公司 2024-06-27 WO claimed
EP-4389130-A1 APPLICATION OF STEROID COMPOUND IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING EYE FLOATERS Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. (CN) 2024-06-26 EP claimed
US-20240190869-A1 5,7-DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES PFIZER (US) 2024-06-13 US claimed
WO-2023116835-A9 MULTI-PROTEIN DEGRADATION AGENT HAVING IMIDE SKELETON 苏州开拓药业股份有限公司 2024-05-02 WO claimed
EP-4337639-A1 NAMPT INHIBITORS AND USES THEREOF Remedy Plan, Inc. (US) 2024-03-20 EP claimed
WO-2023211938-A1 METHODS OF USING A (THIAZOLYL)BENZENESULFONAMIDE DERIVATIVE CYTEIR THERAPEUTICS, INC. (US) 2023-11-02 WO claimed
US-20230192690-A1 5,7-DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES PFIZER (US) 2023-06-22 US claimed
WO-2023051012-A1 ELECTROLYTE ADDITIVE, ELECTROLYTE, AND LITHIUM ION SECONDARY BATTERY COMPRISING ELECTROLYTE 株式会社村田制作所 2023-04-06 WO claimed
EP-4112616-A1 RAD51 INHIBITORS Cyteir Therapeutics, Inc. (US) 2023-01-04 EP claimed
US-20220402869-A1 TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-12-22 US claimed
US-6544298-B1 Dyeing human hair using coupler L'OREAL (FR) 2003-04-08 US claimed
US-20030055012-A1 Prodrugs of COX-2 inhibitors PHARMACIA CORPORATION 2003-03-20 US claimed
EP-1278750-A1 IMIDAZOPYRIMIDINE DERIVATIVES AND TRIAZOLOPYRIMIDINE DERIVATIVES Bayer Aktiengesellschaft (DE) 2003-01-29 EP claimed
US-20020178512-A1 Oxidation dyeing composition for keratinous fibres comprising a n-(2-hydrobenzene)-carbamate or a n-(2-hydroxy-benzene)-urea and a pyrazolopyrimine, dyeing methods L'OREAL SA (FR) 2002-12-05 US claimed
WO-2002092588-A2 AROMATIC SULFONE HYDROXAMATES AND THEIR USE AS PROTEASE INHIBITORS PHARMACIA CORPORATION (US) 2002-11-21 WO claimed
WO-2002083655-A1 PRODRUGS OF COX-2 INHIBITORS PHARMACIA CORPORATION (US) 2002-10-24 WO claimed
US-20020100125-A1 Use of 2-(sulphonylamino) phenols as couplers in oxidation colouring L'OREAL (FR) 2002-08-01 US claimed
WO-2001083485-A1 IMIDAZOPYRIMIDINE DERIVATIVES AND TRIAZOLOPYRIMIDINE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2001-11-08 WO claimed
US-20010034914-A1 Compositions for the oxidation dyeing of keratinous fibers comprising at least one coupler, and dyeing methods L'OREAL S.A. (FR) 2001-11-01 US claimed
US-4845106-A INSECTICIDES NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1989-07-04 US claimed